Dr. Belisa Ann Basile, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 8 Center Square, E Longmeadow, MA 01028 Phone: 413-525-2900 Fax: 413-525-2900 |
News Archive
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the enrollment of the first patient in the company's phase 2b clinical trial of SCV-07 for the prevention of oral mucositis (OM) - a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer.
Scientists at the University of Pennsylvania School of Medicine discovered that a dietary antioxidant found in such vegetables as broccoli and cauliflower protects cells from damage caused by chemicals generated during the body's inflammatory response to infection and injury. The finding has implications for such inflammation-based disorders as cystic fibrosis (CF), diabetes, heart disease, and neurodegeneration.
"Devastating" and "dismal." That's how leading researchers describe the present outlook for malignant brain tumors. The median survival rate for patients with glioblastoma multiforme, or GBM, is a mere 14.2 months.
A new report released at the Substance Abuse and Mental Health Services Administration (SAMHSA) Advisory Committee for Women's Services meeting shows that women aged 18 to 49 on probation or parole are nearly twice as likely to experience mental illness as other women.
Eisai Inc. announced today preliminary results from a randomized Phase III clinical trial of DacogenĀ® (decitabine) for Injection versus either a low-dose chemotherapy agent or supportive care in elderly patients with acute myeloid leukemia (AML), a life-threatening cancer of the blood that generally occurs in older adults.
› Verified 3 days ago